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Abstract
Background: Clinical manifestation due to infection by Toxoplasma gondii is closely linked to the infecting strain of
the parasite. Several genetic markers are available to determinate its genotype but few of them are able to
discriminate between the three predominant lineages, namely types I, II and III. The number of markers decreases
when atypical, recombinant/mixed genotypes need to be identified.
Findings: In our study, the contribution of sequence polymorphisms in the AK69 gene as typing markers for T.
gondii was investigated for the first time in an epidemiological study. The coding region of the marker was
amplified, sequenced and aligned for different Toxoplasma strains. The identified nucleotide polymorphism at 12
positions was able to highly discriminate between the different congenital toxoplasmosis Tunisian strains. Moreover
the high detection sensitivity level of the marker enabled unambiguous identification of mixed/recombinant
genotypes directly.
Conclusion: It can be, thus, very useful for direct typing in areas where such genotypes are frequently
encountered, mainly in the African continent.
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Findings
Toxoplasma gondii (T. gondii) is an intracellular proto-
zoan that infects all warm-blooded animals including
humans. It is considered as one of the most widespread
parasites in the world [1]. While three genetic lineages I,
II and III are predominant in Europe and North Amer-
ica [2], recombinant strains, are rather more frequently
observed in North Africa [3].
Different methods are used for genotypic characteriza-
tion of T.gondii [4,5]. A collection of more than 200
markers, allowing direct genotyping, was described [6].
Nevertheless most of them are biallelic and could distin-
guish just two of the 3 clonal types at a single locus.
Only a small percentage of markers presents two bialle-
lic polymorphisms that lie closely by each other and are
able to identify even recombinant strains. AK69, one of
these markers, located on chromosome X, is the only
one supposed to distinguish between the different types
using a single restriction enzyme [6].
The aim of this study is to investigate the AK69 mar-
ker performance and contribution to the direct charac-
terization of recombinant strains in Tunisia.
This study included 3 reference strains: RH (Type I),
PRU (Type II) and NED (Type III) provided by CRB
Toxoplasma (France) and 14 clinical specimens (11
Amniotic Fluids, 2 Placentas and 1 new born Cerebral
Spinal Fluid) isolated from confirmed congenital toxo-
plasmosis cases [3]. These isolates were characterized
previously by multilocus analysis at six polymorphic
markers [3].
DDesigned primers were used in a PCR assay to
amplify the polymorphic region of AK69 gene. AK69Fex
TTGAACATCTGGTGCGAGAC and AK69Rex GTCTC
CCAACCACCTCCATA were used as external primers
and AK69F ACGAGCAACCATATCTTACC and
AK69R CGAACGGACAACAAGCTA as internal ones.
The annealing temperature was of 55°C for the first
round amplification and 58°C for the second amplifica-
tion round. A starting 1:100 dilution of primary PCR
products was necessary for the second amplification
round. Reaction was carried out in a final volume of 25
μl as described elsewhere [3].
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CleanUp Kit (Sigma Aldrich), and directly sequenced by
Applied Biosystems 3130 Genetic Analyzer. Both for-
ward and reverse PCR internal primers were used for
the sequence reactions. SNPs have been identified, once
sequences aligned.
The AK69 amplified products were also systematically
digested with HinfI as recommended by the supplier
(Invitrogen). The restriction fragments polymorphism
within the locus was resolved by 3% agarose gel, stained
with ethidium bromide and visualised under UV.
To test the sensitivity of the marker, control RH strain
DNA was quantified by spectrometric method at the
wave length of 260 nm and then diluted into aliquots
from 100 ng to 1 fg using 1:10 dilutions. One micro-
liter of each concentration was used in the PCR assay.
The amplified DNA by AK69 external primers gave a
product of 633 base pairs. Small DNA amounts or no
amplification products were detected after the first ampli-
fication round. The external primers were used simulta-
neity with other primers in our multiplex assay [3].
In the second round of amplification, positive reaction
was obtained from all positive tested samples producing
a 490 bp band. Negative controls (Water, Extracted no
DNA, Negative sample) remained free of amplified
products.
To test the sensitivity of the PCR assay, different
quantities of T. gondii DNA were used. Analysis of the
serial dilutions of T. gondii RH pure genomic DNA
established a detection limit of the PCR assay at 100 fg.
Sequences analysis of the three reference strains [Gen-
Bank : HM003613, HM003614 and HM003615] showed
several closely spaced polymorphisms by the presence of
12 substitutions nucleotide (at the positions 111, 125,
142, 155, 195, 215, 221, 250, 291, 324, 326 and 378)
resulting in three-way typing. It reveals four, one
and two HinfI restriction sites for type I, II and III
respectively.
The differential RFLP patterns visualized on the gel
confirmed sequencing results and allowed easy and
unambiguous discrimination of the three strains.
The restriction patterns analysis of AK69 for 13 clini-
cal samples was unequivocal: two samples had type I
allele (AF06/06, AF44/05), two others had type II allele
(AF10/08, AF16/07) and three samples type III allele
(CSF01/08, AF08/08, AF07/06). Five of the remaining
strains revealed mixed profiles between two types: three
strains (AF26/04, AF08/06, and AF33/05) were typed I/
III, two strains (PL05/06, AF19/04) typed I/II and one
strain (PL04/06) was typed II/III. These results have
been confirmed by direct sequencing of the PCR pro-
ducts: the SNPs of the corresponding two types were
superposed on the same sequence [GenBank: JN82707,
JN82708, JN82709 respectively] (Figure 1). The
fourteenth isolate AF07/02 shows after restriction
unique profile (u-1) including the common band of 199
bp and unusual one of approximately 270 bp. The cor-
responding sequence [GenBank: HM003616] revealed
just two restriction HinfI sites at 199 and 221 positions
suggesting thus the concomitant presence of type I and
II. These results are in concordance with previous mul-
tilocus typing of the clinical samples (Table 1).
We report the first use of AK69 marker in an epide-
miological study. Very little is known about this marker:
its chromosomic location and abbreviation which was
suggesting its putative function: adenosine kinase,
despite the fact it was described for the first time in
2005 during the genome map realization of the Toxo-
plasma gondii [6]. Isolates previously studied were typed
to individual level without ambiguity by this three-way
marker. The results were in perfect agreement with the
previous multilocus DNA analysis with regard to the
power of identifying and differentiating these isolates.
Indeed, the use of this marker in typing Tunisian strains
revealed an interesting approach as it allowed solely,
direct identification of final genotype in the half of the
cases which is higher than other marker’s rate (Table 1).
In the other cases, it detected just one of the corre-
sponding allele. Its ability to be used in a multiplex PCR
reaction [3] is a significant advantage since the rate of
identification of the final genotype exceeds 70% with the
supplementary use of GRA6 marker and reaches 100%
with the use of SAG3 marker concerning Tunisian iso-
lates. Our strains were typed to individual level without
ambiguity by these three markers summarizing thus the
result obtained by a 7 locus analysis.
Our results showed that the AK69 marker offers a
new tool for direct identification of strains with promis-
ing alternative for recombinant ones even the small
sample size which is explained by the low rate of the
parasite detection during pregnancy in our country
(these samples were retained positive from 243 analyzed
specimens). Despite this, the performance of the AK69
marker could be very helpful especially in geographic
areas with frequent mixed/recombinant strains like
Africa continent [3]. Its use in a multiplex PCR reaction
presents a further considerable advantage.
In addition, the detection limit of AK69 marker was
shown to be 100 fg of pure toxoplasmic DNA, which
corresponds to one T. gondii organism [7]. AK69 gene
marker was thus revealed to be the most sensitive
described RFLP marker since it is more sensitive that
SAG3 marker: detection limit 1 versus 5 to 10 parasite
[4], making it more suitable to clinical samples with low
parasite load.
Moreover the Blast X of our sequences demonstrated
a perfect match with putative ROP8 protein. This rhop-
try antigen belongs to ROP2 family [8]. This later is
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Page 2 of 4Figure 1 Multiple alignment analysis at AK69 PCR product sequences. Sequences are from the 3 archetypal types I, II, and III (RH, PRU, and
NED respectively) and mixed clinical Tunisian specimens I/III, I/II and II/III (AF33/05, AF 19/04 and PL04/06 respectively). Periods (.) indicates
identical nucleotides related to the sequence of Type I (first row).
Table 1 Summary of AK69 genotyping results and previous multilocus typing of Tunisian clinical strains
Alleles
Samples AK69 3’SAG2 5’SAG2 SAG3 GRA6 BTUB APICO FINAL
AF06/06 1 1 1 1 1 1 1 I
AF44/05 1 1 1 3 1 1 1 I/III
CSF01/08 3 1 1 3 1 1 1 I/III
AF08/08 3 1 1 3 1 1 1 I/III
AF26/04 1+3 1 1 3 1 3 1 I/III
AF08/06 1+3 1 1 3 1 3 3 I/III
AF33/05 1+3 1 1 1+3 1 3 1 I/III
AF07/06 3 1 1 3 1+3 1 1 I/III
PL05/06 1+2 1 1 2 1+2 ND 1 I/II
AF07/02 1+2 1 1 ND 1+2 1+2 1 I/II
AF19/04 1+2 1 1 1+2 1+2 1+2 1 I/II
PL04/06 2+3 1 1 2+3 1 ND 1 I/II/III
AF10/08 2 1 1 2+3 1 ND 1 I/II/III
AF16/07 2 1 1 1+2+3 1 ND 1 I/II/III
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during the invasion process of host cells as well as cru-
cial biological functions [9].
Conclusion
The molecular approaches presented in our work offer
an easy and a highly sensitive discrimination of the dif-
ferent T. gondii strains even in presence of mixed or
new types. A potential implication of this marker in
virulence pathway is also suggested.
Acknowledgements
This study was supported by the Ministry of Higher Education, Research and
Technology in Tunisia and carried out within the framework of the Research
Lab “Parasitoses emergentes” LR 05SP03.
Authors’ contributions
SB carried out the molecular studies, the sequence alignment and drafted
the manuscript. RBA and ES have made substantial contributions to
acquisition of data and their analysis. IBA have been involved in drafting the
manuscript and revised the English typing. OS carried out qPCR for
diagnosis. KA has been involved in revising the manuscript critically for
important intellectual content. AB conceived the study and has given
financial support. All authors approved the final version of the manuscript.
Competing interests
No conflict interest is declared.
Received: 25 July 2011 Accepted: 26 August 2011
Published: 26 August 2011
References
1. Webster Joanne P: Review of “Toxoplasmosis of Animals and Humans
(Second Edition)” by J.P. Dubey. Parasites & Vectors 2010, 3:112.
2. Howe DK, Sibley LD: Toxoplasma gondii comprises three clonal lineages:
correlation of parasite genotype with human disease. J Infect Dis 1995,
172:1561-1566.
3. Boughattas S, Ben-Abdallah R, Siala E, Souissi O, Aoun K, Bouratbine A:
Direct genotypic characterization of Toxoplasma gondii strains
associated with congenital toxoplasmosis in Tunisia (North Africa). Am J
Trop Med Hyg 2010, 82:1041-1046.
4. Khan A, Su C, German M, Storch GA, Clifford DB, Sibley LD: Genotyping of
Toxoplasma gondii strains from immunocompromised patients reveals
high prevalence of type I strains. J Clin Microbiol 2005, 43:5881-5887.
5. Ajzenberg D, Dumètre A, Dardé ML: Multiplex PCR for typing strains of
Toxoplasma gondii. J Clin Microbiol l 2005, 43:1940-1943.
6. Khan A, Taylor S, Su C, Mackey AJ, Boyle J, Cole R, Glover D, Tang K,
Paulsen IT, Berriman M, Boothroyd JC, Pfefferkorn ER, Dubey JP, Ajioka JW,
Roos DS, Wootton JC, Sibley LD: Composite genome map and
recombination parameters derived from three archetypal lineages of
Toxoplasma gondii. Nucleic Acids Res 2005, 33:2980-2982.
7. Cornelissen AW, Overdulve JP, van der Ploeg M: Determination of nuclear
DNA of five eucoccidian parasites, Isospora (Toxoplasma) gondii,
Sarcocystis cruzi, Eimeria tenella, E. acervulina and Plasmodium berghei,
with special reference to gamontogenesis and meiosis in I. (T.) gondii.
Parasitology 1984, 88:531-553.
8. Bradley PJ, Ward C, Cheng SJ, Alexander DL, Coller S, Coombs GH, Dunn JD,
Ferguson DJ, Sanderson SJ, Wastling JM, Boothroyd JC: Proteomic analysis
of rhoptry organelles reveals many novel constituents for host-parasite
interactions in Toxoplasma gondii. J Biol Chem 2005, 280:34245-34258.
9. Dlugonska H: Toxoplasma rhoptries: unique secretory organelles and
source of promising vaccine proteins for immunoprevention of
toxoplasmosis. J Biomed Biotechno 2008, 2008:632-424.
doi:10.1186/1756-3305-4-167
Cite this article as: Boughattas et al.: Tunisian Toxoplasma gondii strains
genotyping by the use of AK69 marker. Parasites & Vectors 2011 4:167.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Boughattas et al. Parasites & Vectors 2011, 4:167
http://www.parasitesandvectors.com/content/4/1/167
Page 4 of 4